Pesquisas alternativas:
nart » nat (Expandir a Pesquisa), nar (Expandir a Pesquisa), nara (Expandir a Pesquisa)
nart » nat (Expandir a Pesquisa), nar (Expandir a Pesquisa), nara (Expandir a Pesquisa)
21
Por Mily, Akhirunnesa, Rekha, Rokeya Sultana, Kamal, S M Mostafa, Akhtar, Evana, Sarker, Protim, Rahim, Zeaur, Gudmundsson, Gudmundur H, Agerberth, Birgitta, Raqib, Rubhana
Publicado em 2013
“... synergistically with 1,25-dihydroxyvitamin D(3) in a lung epithelial cell line. We aimed to evaluate a therapeutic...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
22
Por Kumthekar, P., Grimm, S.A., Marymont, M., Mehta, M., Chandler, J., Muro, K., Jovanovic, B., Helenowski, I., McCarthy, K., Raizer, J.
Publicado em 2014
“...) and ATO 0.20 mg/kg daily in week 1 then twice a week x 5 weeks. RESULTS: Twenty-five patients (14 M and 11...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Artigo
23
24
“... and obese participants accumulated significantly more minutes of overall screen time daily compared...”
Obter o texto integral
Obter o texto integral
Artigo
25
Isolation and Speciation of Candida in Type II Diabetic Patients using CHROM Agar: A Microbial Study
Por Sharma, Usha, Patel, Krupa, Shah, Vandana, Sinha, Surabhi, Rathore, Vishnu Pratap Singh
Publicado no J Clin Diagn Res (2017)
“... individuals without diabetes or any other systemic disease. A total of 3 ml of unstimulated whole saliva...”Publicado no J Clin Diagn Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
26
“... daunorubicin by 3.3 and 13.2 micrograms ml-1 CsA respectively, P less than 0.05. The MST of groups of host mice...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
27
“... to compare two computerised Bayesian dose-individualization methods, ABBOTTBASE and SeBA-GEN, in once-daily...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
28
Por Turpie, Alexander GG
Publicado em 2014
“... from the Phase III ROCKET AF trial, which showed once-daily rivaroxaban to be noninferior to warfarin...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
29
“... of daily activities by 48 h compared to placebo, 87% vs. 63%, p = 0.04. Conclusions We conclude that a...”
Obter o texto integral
Obter o texto integral
Artigo
30
“... day and sorafenib 400 mg once daily. They were followed every 3 months for size, number of focal...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
31
Por Beckford, Kelsey, Grimes, Carley A., Margerison, Claire, Riddell, Lynn J., Skeaff, Sheila A., Nowson, Caryl A.
Publicado no Nutrients (2017)
“... are now replete. However an accurate estimate of daily iodine intake utilizing 24-h urinary iodine...”Publicado no Nutrients (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
32
“... patients and eight age matched controls by comparing accelerations in the 1-3 Hz frequency band...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
33
“... of glycated hemoglobin and an increased incidence of hypoglycemia compared to daily glargine. Conversely...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
34
Por O'Sullivan, Ciara, Edgerly, Maureen, Velarde, Margarita, Wilkerson, Julia, Venkatesan, Aradhana M., Pittaluga, Stefania, Yang, Sherry X., Nguyen, Dat, Balasubramaniam, Sanjeeve, Fojo, Tito
Publicado em 2014
“... of axitinib (AG-013736), a potent, selective inhibitor of VEGFR1, -2, and -3. DESIGN: This was a phase II...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
35
“...: In this multicentre, phase III, open-label, single treatment, 1-year extension study, OROS(® )hydromorphone...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
36
“... of the two medications (QVA149). The choice among the three medications allows a patient to use the same...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
37
Por Asher, David, Padgett, Kyle R, Llorente, Ricardo E, Farnia, Benjamin S, Ford, John C, Gajjar, Shefali R, Mehta, Shahil, Simpson, Garrett N, Dogan, Nesrin, Portelance, Lorraine
Publicado no Cureus (2018)
“...) for tumor localization. We now have the ability to perform daily on-board magnetic resonance imaging (MRI...”Publicado no Cureus (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
38
Por Coles, Alasdair J.
Publicado em 2012
“... of drug development in MS, alemtuzumab has been compared in 1 phase 2 trial and 2 phase 3 trials...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
39
Por Setchell, Kenneth D. R., Brown, Nadine M., Zimmer-Nechemias, Linda, Wolfe, Brian, Jha, Pinky, Heubi, James E.
Publicado em 2014
“...Secoisolariciresinol-diglycoside (SDG), a natural dietary lignan of flaxseeds now available...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
40
Por Mugwanya, Kenneth K., Baeten, Jared M., Wyatt, Christina, Mugo, Nelly R., Celum, Connie L., Ronald, Allan, Kiarie, John, Katabira, Elly, Heffron, Renee
Publicado no J Acquir Immune Defic Syndr (2018)
“... function remains uncertain. We investigated the impact of 6-monthly compared to 3-monthly creatinine...”Publicado no J Acquir Immune Defic Syndr (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo